![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Abbott ramps up Libre 3 production amid shortages
Sep 20, 2024 · MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
Thermo Fisher eliminating 160 jobs, closing Massachusetts facility
Nov 15, 2024 · MedTech industry news. Dive Insight: Demand for viral vectors, which are used in the production of cell and gene therapies, outpaced supply in the late 2010s and into the 2020s as more candidates entered clinical development. Thermo Fisher and other contract development and manufacturing organizations responded by investing in production facilities.
Exactech files for Chapter 11, agrees to investor buyout
Oct 30, 2024 · Dive Brief: Exactech has filed for Chapter 11 bankruptcy protection and agreed to sell its assets to existing investors, the company said Tuesday.; The bankruptcy filing follows Exactech’s failure to reach an out-of-court settlement for product liability claims brought by around 2,600 patients in response to recalls of orthopedic devices, according to a court document.
Top medtech conferences in 2025 | MedTech Dive
Oct 1, 2024 · J.P. Morgan Healthcare Conference. Jan. 13-16 San Francisco. The J.P. Morgan Healthcare Conference is one of the industry’s biggest events. Executives from medical device, hospital and pharmaceutical companies provide insights on their recent financial performance and developments to watch in the year ahead.
J&J’s Ottava surgical robot to begin clinical trial after FDA nod
Nov 12, 2024 · Dive Brief: Johnson & Johnson said Tuesday it received an investigational device exemption (IDE) from the Food and Drug Administration to start a U.S. clinical trial for its Ottava surgical robot.; The company said it will now prepare U.S. sites to receive Ottava systems, enroll patients and begin surgical cases as it focuses on training clinical trial investigators.
Zimmer pulls hip implant off the market due to fracture risk
Sep 18, 2024 · Dive Brief: Zimmer Biomet will phase out sales of its CPT Hip System by December due to concerns about the risk of thigh bone fractures, the Food and Drug Administration said in a Tuesday notice.; Despite plans to pull the device, the FDA said it is still concerned about the hip system being implanted in new patients, and it is “working with the manufacturer to address these concerns.”
Medtech firms have cut thousands of jobs this year. Will layoffs ...
Dec 18, 2024 · Medtech firms have cut thousands of workers in the last two years, leaving employees wondering what’s to come in 2025. In the past two months, DNA testing company 23&Me announced plans to cut 200 jobs, orthopedics firm Smith & Nephew announced plans to cut 150 jobs and diabetes tech firm Embecta said it would cut 125 positions after discontinuing its insulin patch pump program.
Henry Schein to acquire medical supplier Acentus
Nov 21, 2024 · Dive Brief: Henry Schein said Wednesday it had agreed to acquire Acentus, a medical supplier specializing in delivering products to patients’ homes.; Henry Schein, a medical and dental supplies distributor, said the acquisition brings its homecare medical products platform’s annual revenue base to approximately $350 million.